Brief: Neovacs Is Studying Four Investment Opportunities In Innovative Companies

Neovacs SA

16/02/2021 07:23

Feb 16 (Reuters) - NEOVACS SA  ALNEV.PA :
    * HAS AN IMMEDIATELY AVAILABLE CASH RESERVE OF AROUND €9.4M,
I.E.
55% OF AVAILABLE CASH
    * AIMS TO USE THE SKILLS OF ITS EXPERIENCED SCIENTIFIC TEAM
TO
IDENTIFY PROMISING PROJECTS, BOTH IN THE DEVELOPMENT OF DRUG
CANDIDATES (BIOTECH) AND MEDICAL DEVICES (MEDTECH)
    * FILE SELECTION PROCESS IS PROGRESSING AND NEOVACS IS
CURRENTLY
STUDYING 4 INVESTMENT OPPORTUNITIES IN INNOVATIVE COMPANIES
LOOKING FOR PARTNERS

Source text: https://bit.ly/2ZmSXqq
Further company coverage:  ALNEV.PA 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))